Related Experiment Video
Updated: Jan 19, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
[Multiorgan manifestations in myotonic dystrophy type 1]
1Klinikai Központ, Neurológiai Klinika, Pécsi Tudományegyetem, Általános Orvostudományi Kar Pécs, Rét u. 2., 7623.
Myotonic dystrophy, an inherited muscle disorder, presents with distinct types and affects multiple body systems. Early diagnosis and individualized care are crucial for managing this condition and improving patient outcomes.
Area of Science:
- Neurology
- Genetics
- Internal Medicine
Background:
- Myotonic dystrophy is a common autosomal dominant inherited adult-onset muscle disorder.
- It presents in two main types: type 1 (distal weakness, myotonia) and type 2 (proximal weakness, milder course).
- Also known as Steinert Disease, it affects multiple organ systems, impacting quality of life and survival.
Purpose of the Study:
- To highlight the clinical manifestations of myotonic dystrophy.
- To discuss diagnostic approaches for the disease.
- To provide recommendations for optimal patient care.
Main Methods:
- Review of clinical conditions associated with myotonic dystrophy.
- Discussion of diagnostic strategies.
- Formulation of care recommendations for healthcare providers.
Main Results:
- Myotonic dystrophy involves systemic complications affecting the heart, endocrine glands, eyes, and metabolism.
- These systemic effects significantly impact patient quality of life and survival.
- Various diagnostic tools are available for identifying the condition.
Conclusions:
- Optimal and individualized care is essential for patients with myotonic dystrophy.
- Recommendations are provided to assist neurologists and general practitioners in patient management.
- Emphasizing clinical conditions and diagnostic possibilities aids in better patient outcomes.
Related Concept Videos
09:39Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
05:54A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy
04:26Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
Satellite Stem Cells and Muscular Dystrophy
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
09:11Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

